25 XP   0   0   10

Petros Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Petros Pharmaceuticals Inc together

PenkeI guess you are interested in Petros Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Petros Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Petros Pharmaceuticals Inc

I send you an email if I find something interesting about Petros Pharmaceuticals Inc.

Quick analysis of Petros Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Petros Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.82
Expected worth in 1 year
$1.38
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$-0.43
Return On Investment
-63.5%

For what price can you sell your share?

Current Price per Share
$0.68
Expected price per share
$0 - $1.0445
How sure are you?
50%

1. Valuation of Petros Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$0.68

Intrinsic Value Per Share

$-24.59 - $-28.91

Total Value Per Share

$-22.77 - $-27.09

2. Growth of Petros Pharmaceuticals Inc (5 min.)




Is Petros Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$12.4m$21.7m-$10.5m-93.6%

How much money is Petros Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$59.8m$58.2m3,606.2%
Net Profit Margin-143.5%-2,085.1%--

How much money comes from the company's main activities?

3. Financial Health of Petros Pharmaceuticals Inc (5 min.)




What can you expect buying and holding a share of Petros Pharmaceuticals Inc? (5 min.)

Welcome investor! Petros Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Petros Pharmaceuticals Inc.

What can you expect buying and holding a share of Petros Pharmaceuticals Inc?

First you should know what it really means to hold a share of Petros Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Petros Pharmaceuticals Inc is $0.6801. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Petros Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Petros Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.82. Based on the TTM, the Book Value Change Per Share is $-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.74 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Petros Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.056.8%-0.23-34.5%-0.67-98.4%-0.47-68.7%-0.47-68.7%
Usd Book Value Change Per Share0.000.0%-0.11-15.9%-0.74-108.4%0.1115.7%0.1115.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%-0.11-15.9%-0.74-108.4%0.1115.7%0.1115.7%
Usd Price Per Share1.48-1.66-1.27-1.76-1.76-
Price to Earnings Ratio8.00-3.40--1.37--0.70--0.70-
Price-to-Total Gains Ratio-1.94--3.94-1.89-1.89-
Price to Book Ratio0.82-1.09-0.48-0.71-0.71-
Price-to-Total Gains Ratio-1.94--3.94-1.89-1.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6801
Number of shares1470
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.110.11
Usd Total Gains Per Share-0.110.11
Gains per Quarter (1470 shares)-158.61156.95
Gains per Year (1470 shares)-634.46627.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-634-6440628618
20-1269-1278012561246
30-1903-1912018831874
40-2538-2546025112502
50-3172-3180031393130
60-3807-3814037673758
70-4441-4448043954386
80-5076-5082050225014
90-5710-5716056505642
100-6345-6350062786270

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%3.014.00.017.6%3.014.00.017.6%3.014.00.017.6%
Book Value Change Per Share1.02.01.025.0%3.08.01.025.0%5.08.04.029.4%5.08.04.029.4%5.08.04.029.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.02.01.025.0%3.08.01.025.0%5.08.04.029.4%5.08.04.029.4%5.08.04.029.4%

Fundamentals of Petros Pharmaceuticals Inc

About Petros Pharmaceuticals Inc

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.

Fundamental data was last updated by Penke on 2024-04-12 15:57:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Petros Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Petros Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -87.3% means that $-0.87 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Petros Pharmaceuticals Inc:

  • The MRQ is -87.3%. The company is making a huge loss. -2
  • The TTM is -143.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-87.3%TTM-143.5%+56.2%
TTM-143.5%YOY-2,085.1%+1,941.6%
TTM-143.5%5Y-527.0%+383.5%
5Y-527.0%10Y-527.0%0.0%
1.1.2. Return on Assets

Shows how efficient Petros Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.9% Return on Assets means that Petros Pharmaceuticals Inc generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Petros Pharmaceuticals Inc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -4.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-4.7%+5.6%
TTM-4.7%YOY-192.8%+188.1%
TTM-4.7%5Y-47.4%+42.7%
5Y-47.4%10Y-47.4%0.0%
1.1.3. Return on Equity

Shows how efficient Petros Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.5% Return on Equity means Petros Pharmaceuticals Inc generated $0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Petros Pharmaceuticals Inc:

  • The MRQ is 2.5%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -20.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.5%TTM-20.1%+22.6%
TTM-20.1%YOY-379.5%+359.5%
TTM-20.1%5Y-97.0%+76.9%
5Y-97.0%10Y-97.0%0.0%

1.2. Operating Efficiency of Petros Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Petros Pharmaceuticals Inc is operating .

  • Measures how much profit Petros Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 1,320.8% means the company generated $13.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Petros Pharmaceuticals Inc:

  • The MRQ is 1,320.8%. The company is operating very efficient. +2
  • The TTM is 228.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ1,320.8%TTM228.2%+1,092.6%
TTM228.2%YOY83.1%+145.1%
TTM228.2%5Y47.0%+181.2%
5Y47.0%10Y47.0%0.0%
1.2.2. Operating Ratio

Measures how efficient Petros Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of -12.83 means that the operating costs are $-12.83 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Petros Pharmaceuticals Inc:

  • The MRQ is -12.833.
  • The TTM is -5.060.
Trends
Current periodCompared to+/- 
MRQ-12.833TTM-5.060-7.773
TTM-5.060YOY1.448-6.508
TTM-5.0605Y-0.011-5.049
5Y-0.01110Y-0.0110.000

1.3. Liquidity of Petros Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Petros Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.89 means the company has $1.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Petros Pharmaceuticals Inc:

  • The MRQ is 1.893. The company is able to pay all its short-term debts. +1
  • The TTM is 2.115. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.893TTM2.115-0.222
TTM2.115YOY2.389-0.274
TTM2.1155Y1.427+0.688
5Y1.42710Y1.4270.000
1.3.2. Quick Ratio

Measures if Petros Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.44 means the company can pay off $1.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Petros Pharmaceuticals Inc:

  • The MRQ is 1.445. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.373. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.445TTM1.373+0.072
TTM1.373YOY1.919-0.545
TTM1.3735Y1.064+0.309
5Y1.06410Y1.0640.000

1.4. Solvency of Petros Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Petros Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Petros Pharmaceuticals Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.63 means that Petros Pharmaceuticals Inc assets are financed with 63.1% credit (debt) and the remaining percentage (100% - 63.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Petros Pharmaceuticals Inc:

  • The MRQ is 0.631. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.657. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.631TTM0.657-0.027
TTM0.657YOY0.440+0.217
TTM0.6575Y0.469+0.189
5Y0.46910Y0.4690.000
1.4.2. Debt to Equity Ratio

Measures if Petros Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 170.8% means that company has $1.71 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Petros Pharmaceuticals Inc:

  • The MRQ is 1.708. The company is just able to pay all its debts with equity.
  • The TTM is 2.308. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.708TTM2.308-0.600
TTM2.308YOY0.808+1.499
TTM2.3085Y1.347+0.960
5Y1.34710Y1.3470.000

2. Market Valuation of Petros Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Petros Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Petros Pharmaceuticals Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 8.00 means the investor is paying $8.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Petros Pharmaceuticals Inc:

  • The EOD is 3.675. Based on the earnings, the company is cheap. +2
  • The MRQ is 7.996. Based on the earnings, the company is underpriced. +1
  • The TTM is 3.398. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.675MRQ7.996-4.322
MRQ7.996TTM3.398+4.599
TTM3.398YOY-1.371+4.768
TTM3.3985Y-0.695+4.093
5Y-0.69510Y-0.6950.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Petros Pharmaceuticals Inc:

  • The EOD is -0.517. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.126. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.276. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.517MRQ-1.126+0.608
MRQ-1.126TTM-2.276+1.150
TTM-2.276YOY-1.650-0.626
TTM-2.2765Y-2.271-0.005
5Y-2.27110Y-2.2710.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Petros Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Petros Pharmaceuticals Inc:

  • The EOD is 0.375. Based on the equity, the company is cheap. +2
  • The MRQ is 0.815. Based on the equity, the company is cheap. +2
  • The TTM is 1.089. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.375MRQ0.815-0.441
MRQ0.815TTM1.089-0.274
TTM1.089YOY0.480+0.609
TTM1.0895Y0.709+0.380
5Y0.70910Y0.7090.000
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Petros Pharmaceuticals Inc.

3.1. Institutions holding Petros Pharmaceuticals Inc

Institutions are holding 1.698% of the shares of Petros Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.445303181100
2023-12-31Virtu Financial LLC1.12790.002824825248250
2023-09-30Schonfeld Strategic Advisors LLC1.03130.000322700-500-2.1552
2023-12-31BlackRock Inc0.7539016594840.5088
2023-09-30Citadel Advisors Llc0.6491014288142880
2023-12-31Geode Capital Management, LLC0.477101050200
2023-12-31Tower Research Capital LLC0.41470.000291276585259.048
2023-12-31EMFO, LLC0.04540.0013100000
2023-12-31Newbridge Financial Services Group, Inc.0.00550.000112000
2023-12-31Group One Trading, LP0.003607900
2023-12-31FMR Inc0.0009020200
2023-12-31Morgan Stanley - Brokerage Accounts0.000901900
2023-12-31Advisor Group Holdings, Inc.0.000601400
2023-12-31Wells Fargo & Co0.000501219.0909
2023-12-311832 Asset Management L.P0.0005010100
2023-12-31First Manhattan Co. LLC0.000501000
2023-12-31Bank of America Corp00100
2023-09-30Bank of Montreal000-10000-100
2023-09-30BMO Capital Markets Corp.000-10000-100
2023-09-30Renaissance Technologies Corp000-16779-100
Total 5.95770.0047131132+8534+6.5%

3.2. Funds holding Petros Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.44530.00013181100
2024-02-29Fidelity Extended Market Index0.36410801300
2024-02-29Fidelity Series Total Market Index0.05270116000
2024-02-29Fidelity Nasdaq Composite Index0.0306067400
2024-02-29Spartan Total Market Index Pool E0.0248054500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0232051000
2023-12-31Northern Trust Extended Eq Market Idx0.0232051000
2023-09-30BlackRock Extended Mkt Composite0.0174038200
2024-03-31BlackRock Extended Equity Market K0.0151033300
2023-12-31SSgA U.S. Extended Market Index Class I0.0086019000
2024-03-31State St US Extended Mkt Indx NL Cl C0.0086019000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0054011800
2024-02-29Fidelity Total Market Index0.005011000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.004309500
2023-12-31SSgA U.S. Total Market Index Strategy0.0025055-1-1.7857
2023-12-31NT US Market Cap Idx Fd - L0.002405200
2023-12-31Northern Trust Wilshire 50000.002405200
2023-12-31NT Quality SCC US Fund - L0.002305100
2023-12-31NT Quality Small Cap Core0.002305100
2024-03-31Extended Equity Market Fund M0.001904100
Total 2.04210.000144943-10.0%

3.3. Insider Transactions

Insiders are holding 11.797% of the shares of Petros Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2021-11-29John D ShulmanBUY5000030
2021-10-18John D ShulmanBUY16618017.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Petros Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.1080%-0.7370%0.107-100%0.107-100%
Book Value Per Share--1.8151.635+11%3.166-43%2.387-24%2.387-24%
Current Ratio--1.8932.115-10%2.389-21%1.427+33%1.427+33%
Debt To Asset Ratio--0.6310.657-4%0.440+43%0.469+35%0.469+35%
Debt To Equity Ratio--1.7082.308-26%0.808+111%1.347+27%1.347+27%
Dividend Per Share----0%-0%-0%-0%
Eps--0.046-0.235+608%-0.669+1547%-0.467+1110%-0.467+1110%
Free Cash Flow Per Share---0.329-0.319-3%-0.301-9%-0.423+29%-0.423+29%
Free Cash Flow To Equity Per Share---0.674-0.102-85%-0.340-50%0.029-2434%0.029-2434%
Gross Profit Margin--1.0001.0000%1.0000%1.130-11%1.130-11%
Intrinsic Value_10Y_max---28.909--------
Intrinsic Value_10Y_min---24.590--------
Intrinsic Value_1Y_max---1.821--------
Intrinsic Value_1Y_min---1.788--------
Intrinsic Value_3Y_max---6.291--------
Intrinsic Value_3Y_min---5.990--------
Intrinsic Value_5Y_max---11.750--------
Intrinsic Value_5Y_min---10.836--------
Market Cap4676238.381-118%10176198.80011430862.230-11%8723340.147+17%12083103.589-16%12083103.589-16%
Net Profit Margin---0.873-1.435+64%-20.851+2287%-5.270+503%-5.270+503%
Operating Margin--13.2082.282+479%0.831+1490%0.470+2711%0.470+2711%
Operating Ratio---12.833-5.060-61%1.448-986%-0.011-100%-0.011-100%
Pb Ratio0.375-118%0.8151.089-25%0.480+70%0.709+15%0.709+15%
Pe Ratio3.675-118%7.9963.398+135%-1.371+117%-0.695+109%-0.695+109%
Price Per Share0.680-118%1.4801.662-11%1.269+17%1.757-16%1.757-16%
Price To Free Cash Flow Ratio-0.517+54%-1.126-2.276+102%-1.650+47%-2.271+102%-2.271+102%
Quick Ratio--1.4451.373+5%1.919-25%1.064+36%1.064+36%
Return On Assets--0.009-0.047+596%-1.928+20582%-0.474+5136%-0.474+5136%
Return On Equity--0.025-0.201+887%-3.795+14988%-0.970+3904%-0.970+3904%
Total Gains Per Share----0.1080%-0.7370%0.107-100%0.107-100%
Usd Book Value--12480023.00011240352.500+11%21765536.500-43%16413235.471-24%16413235.471-24%
Usd Book Value Change Per Share----0.1080%-0.7370%0.107-100%0.107-100%
Usd Book Value Per Share--1.8151.635+11%3.166-43%2.387-24%2.387-24%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.046-0.235+608%-0.669+1547%-0.467+1110%-0.467+1110%
Usd Free Cash Flow---2259894.000-2195932.750-3%-2067496.750-9%-2911575.000+29%-2911575.000+29%
Usd Free Cash Flow Per Share---0.329-0.319-3%-0.301-9%-0.423+29%-0.423+29%
Usd Free Cash Flow To Equity Per Share---0.674-0.102-85%-0.340-50%0.029-2434%0.029-2434%
Usd Market Cap4676238.381-118%10176198.80011430862.230-11%8723340.147+17%12083103.589-16%12083103.589-16%
Usd Price Per Share0.680-118%1.4801.662-11%1.269+17%1.757-16%1.757-16%
Usd Profit--318150.000-1614972.750+608%-59853967.000+18913%-15995627.588+5128%-15995627.588+5128%
Usd Revenue---364250.000735042.000-150%1511214.250-124%1695348.647-121%1695348.647-121%
Usd Total Gains Per Share----0.1080%-0.7370%0.107-100%0.107-100%
 EOD+3 -4MRQTTM+16 -12YOY+11 -175Y+14 -1910Y+14 -19

4.2. Fundamental Score

Let's check the fundamental score of Petros Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.675
Price to Book Ratio (EOD)Between0-10.375
Net Profit Margin (MRQ)Greater than0-0.873
Operating Margin (MRQ)Greater than013.208
Quick Ratio (MRQ)Greater than11.445
Current Ratio (MRQ)Greater than11.893
Debt to Asset Ratio (MRQ)Less than10.631
Debt to Equity Ratio (MRQ)Less than11.708
Return on Equity (MRQ)Greater than0.150.025
Return on Assets (MRQ)Greater than0.050.009
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Petros Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.558
Ma 20Greater thanMa 500.955
Ma 50Greater thanMa 1001.312
Ma 100Greater thanMa 2001.312
OpenGreater thanClose0.691
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets33,796
Total Liabilities21,316
Total Stockholder Equity12,480
 As reported
Total Liabilities 21,316
Total Stockholder Equity+ 12,480
Total Assets = 33,796

Assets

Total Assets33,796
Total Current Assets20,390
Long-term Assets13,405
Total Current Assets
Cash And Cash Equivalents 13,337
Net Receivables 2,226
Inventory 1,610
Other Current Assets 816
Total Current Assets  (as reported)20,390
Total Current Assets  (calculated)17,990
+/- 2,401
Long-term Assets
Property Plant Equipment 255
Long-term Assets Other 4,178
Long-term Assets  (as reported)13,405
Long-term Assets  (calculated)4,434
+/- 8,972

Liabilities & Shareholders' Equity

Total Current Liabilities10,771
Long-term Liabilities10,545
Total Stockholder Equity12,480
Total Current Liabilities
Short-term Debt 1,282
Accounts payable 1,713
Other Current Liabilities 5,728
Total Current Liabilities  (as reported)10,771
Total Current Liabilities  (calculated)8,723
+/- 2,048
Long-term Liabilities
Long-term Liabilities  (as reported)10,545
Long-term Liabilities  (calculated)0
+/- 10,545
Total Stockholder Equity
Common Stock0
Retained Earnings -98,890
Other Stockholders Equity 110,960
Total Stockholder Equity (as reported)12,480
Total Stockholder Equity (calculated)12,071
+/- 409
Other
Cash and Short Term Investments 13,337
Common Stock Shares Outstanding 139
Current Deferred Revenue2,048
Liabilities and Stockholders Equity 33,796
Net Debt -5,060
Net Working Capital 9,620
Short Long Term Debt Total 8,277



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
69,854
66,154
56,670
52,035
67,390
55,864
51,050
37,696
32,421
30,570
28,727
38,914
33,796
33,796
33,79633,79638,91428,72730,57032,42137,69651,05055,86467,39052,03556,67066,15469,854000
   > Total Current Assets 
10,913
6,872
10,454
25,905
23,964
16,234
13,354
30,543
26,838
22,853
18,772
14,668
13,903
13,151
24,433
20,390
20,390
20,39020,39024,43313,15113,90314,66818,77222,85326,83830,54313,35416,23423,96425,90510,4546,87210,913
       Cash And Cash Equivalents 
0
0
0
17,140
14,567
11,031
8,135
23,848
17,672
13,295
11,182
9,426
8,320
7,385
17,970
13,337
13,337
13,33713,33717,9707,3858,3209,42611,18213,29517,67223,8488,13511,03114,56717,140000
       Net Receivables 
4,085
1,114
4,154
5,153
6,194
2,021
1,952
3,064
4,350
5,852
3,837
2,110
2,400
2,577
2,975
2,226
2,226
2,2262,2262,9752,5772,4002,1103,8375,8524,3503,0641,9522,0216,1945,1534,1541,1144,085
       Inventory 
1,950
1,794
1,567
761
561
439
518
520
1,943
1,909
2,154
1,815
2,038
2,180
2,501
1,610
1,610
1,6101,6102,5012,1802,0381,8152,1541,9091,9435205184395617611,5671,7941,950
       Other Current Assets 
2,420
2,100
2,340
1,419
1,402
1,441
1,917
1,530
1,495
789
694
802
746
716
987
816
816
8168169877167468026947891,4951,5301,9171,4411,4021,4192,3402,1002,420
   > Long-term Assets 
0
0
0
43,949
42,190
40,436
38,681
36,847
29,026
28,197
18,925
17,753
16,667
15,576
14,481
13,405
13,405
13,40513,40514,48115,57616,66717,75318,92528,19729,02636,84738,68140,43642,19043,949000
       Property Plant Equipment 
722
696
671
644
611
584
555
525
494
463
431
398
364
328
292
255
255
255255292328364398431463494525555584611644671696722
       Intangible Assets 
0
0
0
32,161
30,434,646
28,708,372
26,982,098
25,293
23,734,834
22,177
13,158
25,293,149
11,420,244
10,596,004
9,772
0
0
009,77210,596,00411,420,24425,293,14913,15822,17723,734,83425,29326,982,09828,708,37230,434,64632,161000
       Long-term Assets Other 
0
0
0
11,144
11,144
11,144
11,144
11,029
4,797
5,557
5,336
5,111
4,883
4,652
4,417
4,178
4,178
4,1784,1784,4174,6524,8835,1115,3365,5574,79711,02911,14411,14411,14411,144000
> Total Liabilities 
0
0
0
52,385
45,231
37,180
34,188
31,845
20,138
16,833
17,001
15,719
15,123
15,783
31,857
21,316
21,316
21,31621,31631,85715,78315,12315,71917,00116,83320,13831,84534,18837,18045,23152,385000
   > Total Current Liabilities 
43,321
51,704
56,789
41,894
40,220
34,490
33,501
30,980
10,289
7,377
7,945
7,068
6,885
7,965
8,082
10,771
10,771
10,77110,7718,0827,9656,8857,0687,9457,37710,28930,98033,50134,49040,22041,89456,78951,70443,321
       Short-term Debt 
0
0
0
7,175
5,061
3,425
1,741
7,175,029
724
905
906
1,090
1,106
1,123
1,288
0
1,282
1,28201,2881,1231,1061,0909069057247,175,0291,7413,4255,0617,175000
       Short Long Term Debt 
0
0
0
7,175
5,061
3,425
1,741
0
724
905
906
1,090
1,106
1,123
1,139
1,157
0
01,1571,1391,1231,1061,09090690572401,7413,4255,0617,175000
       Accounts payable 
5,132
5,698
8,302
5,610
5,276
2,598
5,312
4,558
3,700
1,905
2,085
1,806
1,858
1,784
1,355
1,713
1,713
1,7131,7131,3551,7841,8581,8062,0851,9053,7004,5585,3122,5985,2765,6108,3025,6985,132
       Other Current Liabilities 
27,988
20,920
20,221
222
297
498
649
261
5,864
4,567
4,954
4,172
3,921
280
4,070
368
5,728
5,7283684,0702803,9214,1724,9544,5675,86426164949829722220,22120,92027,988
   > Long-term Liabilities 
0
0
0
10,491
5,011
2,690
688
865
9,849
9,456
9,057
8,651
8,237
7,817
23,775
10,545
10,545
10,54510,54523,7757,8178,2378,6519,0579,4569,8498656882,6905,01110,491000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-7,175
-5,061
-3,425
-1,303
-7,174,624
-353
-569
-606
-827
-882
-939
-988
263
-1,282
-1,282263-988-939-882-827-606-569-353-7,174,624-1,303-3,425-5,061-7,175000
       Long-term Liabilities Other 
0
0
0
601
501
470
0
0
0
0
0
0
0
0
0
0
0
00000000000470501601000
> Total Stockholder Equity
0
0
0
17,469
20,923
19,491
17,847
35,545
35,727
34,217
20,695
16,702
15,448
12,944
6,933
12,480
12,480
12,48012,4806,93312,94415,44816,70220,69534,21735,72735,54517,84719,49120,92317,469000
   Common Stock
29,117
29,117
29,117
1
1
1
1
2
2
2
2
0
0
0
0
0
0
0000002222111129,11729,11729,117
   Retained Earnings -98,890-98,890-99,208-94,658-92,112-90,726-86,505-72,675-70,863-70,689-62,503-60,806-58,693-61,702-56,264-52,964-47,199
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
79,170
79,615
80,296
80,349
106,232
106,588
106,890
107,198
107,429
107,559
107,602
106,140
0
110,960
110,9600106,140107,602107,559107,429107,198106,890106,588106,23280,34980,29679,61579,170000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,822
Cost of Revenue-4,914
Gross Profit908908
 
Operating Income (+$)
Gross Profit908
Operating Expense-11,671
Operating Income-10,762-10,762
 
Operating Expense (+$)
Research Development2,409
Selling General Administrative9,306
Selling And Marketing Expenses0
Operating Expense11,67111,715
 
Net Interest Income (+$)
Interest Income302
Interest Expense-536
Other Finance Cost-19
Net Interest Income-253
 
Pretax Income (+$)
Operating Income-10,762
Net Interest Income-253
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,163-13,362
EBIT - interestExpense = -11,298
5,643,048
-7,627
Interest Expense536
Earnings Before Interest and Taxes (EBIT)-10,762-7,627
Earnings Before Interest and Taxes (EBITDA)-7,347
 
After tax Income (+$)
Income Before Tax-8,163
Tax Provision-0
Net Income From Continuing Ops-12,703-8,163
Net Income-8,163
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,585
Total Other Income/Expenses Net2,599253
 

Technical Analysis of Petros Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Petros Pharmaceuticals Inc. The general trend of Petros Pharmaceuticals Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Petros Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Petros Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.9172 < 1.04 < 1.0445.

The bearish price targets are: .

Tweet this
Petros Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Petros Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Petros Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Petros Pharmaceuticals Inc. The current macd is -0.19490598.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Petros Pharmaceuticals Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Petros Pharmaceuticals Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Petros Pharmaceuticals Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Petros Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartPetros Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Petros Pharmaceuticals Inc. The current adx is 33.62.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Petros Pharmaceuticals Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Petros Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Petros Pharmaceuticals Inc. The current sar is 0.84589034.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Petros Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Petros Pharmaceuticals Inc. The current rsi is 25.56. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Petros Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartPetros Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Petros Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Petros Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Petros Pharmaceuticals Inc Daily Stochastic Oscillator ChartPetros Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Petros Pharmaceuticals Inc. The current cci is -86.72705319.

Petros Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartPetros Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Petros Pharmaceuticals Inc. The current cmo is -56.18596891.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Petros Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartPetros Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Petros Pharmaceuticals Inc. The current willr is -87.10734772.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Petros Pharmaceuticals Inc Daily Williams %R ChartPetros Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Petros Pharmaceuticals Inc.

Petros Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Petros Pharmaceuticals Inc. The current atr is 0.11161733.

Petros Pharmaceuticals Inc Daily Average True Range (ATR) ChartPetros Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Petros Pharmaceuticals Inc. The current obv is 116,734,906.

Petros Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartPetros Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Petros Pharmaceuticals Inc. The current mfi is 25.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Petros Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartPetros Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Petros Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Petros Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Petros Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.558
Ma 20Greater thanMa 500.955
Ma 50Greater thanMa 1001.312
Ma 100Greater thanMa 2001.312
OpenGreater thanClose0.691
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Petros Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Petros Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Petros Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Petros Pharmaceuticals Inc

I send you an email if I find something interesting about Petros Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Petros Pharmaceuticals Inc.

Receive notifications about Petros Pharmaceuticals Inc in your mailbox!